Tissue inhibitor of metalloproteinase 2 (TIMP2) is a crucial endogenous inhibitor of matrix metalloproteinase-2 (MMP-2) [9], and its expression changes are associated with the development of ischemic stroke and intracerebral hemorrhage [10]. The gene discussed is MMP2; the disease is ischemic stroke.